United States Drug Enforcement Administration

MIAMI – A south Florida defendant pled guilty to participating in a conspiracy to possess with intent to distribute a synthetic opioid, protonitazene. Will Catis, Sr. (Catis), 42, of Deerfield Beach, pled guilty before U.S. District Judge Raag Singhal. According to the agreed upon factual proffer, on April 12, 2022...

MIAMI – Dr. Ronald Lubetsky was sentenced this week to five (5) years in prison by U.S. District Judge Donald M. Middlebrooks for unlawfully dispensing narcotics—specifically oxycodone and morphine. Lubetsky was convicted at trial in November on seven counts of unlawfully dispensing narcotics. Trial evidence showed that law enforcement learned...

MIAMI – On Sunday, August 21, the Drug Enforcement Administration (DEA) will recognize National Fentanyl Prevention and Awareness Day by joining the many voices dedicated to educating the public on the serious dangers of fentanyl poisoning from fake pills and other illicit drugs. DEA supports the efforts of several organizations...

MIAMI - Today, the Drug Enforcement Administration (DEA) Miami Field Division has issued a Public Safety Alert to warn Florida communities of the increase of mass-overdose events across the state suspected to be related to drug supplies laced with a synthetic opioid. While law enforcement agencies continue to investigate these...

Thank you and good morning. Thank you to ONDCP and to all the federal partners with whom we have been working on this important issue. This is a critical moment in our country. DEA’s mission is to keep American communities safe and healthy and we are in the midst of...

MIAMI - Today, the United States Drug Enforcement Administration launched a new comprehensive law enforcement and prevention initiative aimed at reducing drug use, abuse, and overdose deaths. “Operation Engage” allows participating field divisions to focus on the biggest drug threat and resulting violence in their respective geographic areas. The initiative...

WASHINGTON – With the unprecedented worldwide health emergency brought on by COVID-19, last year was filled with new challenges and increased risks. While much of the world focused on combating the pandemic, DEA continued to implement initiatives to combat violent drug traffickers who were intent on flooding cities and rural...

MIAMI – DEA Miami Division Special Agent in Charge Adolphus P. Wright today announced the results of a three-day, statewide enforcement operation targeting opioids. The DEA-led surge brought together hundreds of federal, state and local law enforcement agencies throughout Florida. The operation targeted all levels of opioid distributors in the...

WASHINGTON – The Drug Enforcement Administration today announced action against a dangerous designer synthetic cathinone linked to 151 overdose deaths in the United States between 2015 and 2018. Published in today’s Federal Register, DEA’s action puts N-Ethylpentylone into Schedule I of the Controlled Substances Act. Schedule I substances refer to...

WASHINGTON – The Department of Justice and U.S. Drug Enforcement Administration have proposed a reduction for controlled substances that may be manufactured in the U.S. next year. Consistent with President Trump’s “Safe Prescribing Plan” that seeks to “cut nationwide opioid prescription fills by one-third within three years,” the proposal decreases...